Effect of Dose and Combination of Antihypertensives on Interindividual Blood Pressure Variability
- 1 October 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 42 (10), 2860-2865
- https://doi.org/10.1161/strokeaha.110.611566
Abstract
Background and Purpose—: Recent studies have shown that visit-to-visit blood pressure variability is a powerful risk factor for stroke, is reduced by calcium channel blockers and diuretics, and increased by β-blockers. However, it is unknown whether these effects are dose-dependent and persist in combination with other drugs. Methods—: Cochrane and Medline databases were searched for systematic reviews and randomized controlled trials of antihypertensive drugs. Eligible trials randomized all patients to a combination of drug classes or different doses of the same drug. Baseline and follow-up data for mean (SD) systolic blood pressure (SBP) and diastolic blood pressure were extracted. Differences in interindividual variance (SD 2 ) in blood pressure were expressed as a ratio (VR). Estimates were pooled by random-effects meta-analysis. Results—: Calcium channel blockers reduced interindividual variability in SBP when added to another agent (VR, 0.75; 95% CI, 0.64 to 0.87; P =0.0002; 12 trials; 1565 patients) with a smaller reduction with diuretics (VR, 0.85; 0.71 to 1.01; P =0.07; 17 trials; 3217 patients). Adding other agents to calcium channel blockers did not significantly affect SBP variability (VR, 1.06; 0.83 to 1.34; P =0.65; 12 trials; 1460 patients) despite a 5.8-mm Hg reduction in mean SBP. Randomization to a higher dose of calcium channel blockers reduced SBP variability (VR, 0.84; 0.74 to 0.94; P =0.004; 25 trials; 2179 patients), whereas randomization to a higher dose of β-blockers increased SBP variability (VR, 1.31; 1.01 to 1.69; P =0.034; 6 trials; 486 patients). Conclusions—: Effects of antihypertensive drugs on SBP variability are dose-dependent and persist when used in combinations. Use of a high dose of a calcium channel blocker alone or in combination with other agents is therefore likely to be particularly effective in prevention of stroke.Keywords
This publication has 35 references indexed in Scilit:
- Safety and benefits of a tablet combining losartan and hydrochlorothiazide in Japanese diabetic patients with hypertensionHypertension Research, 2009
- Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertensionHypertension Research, 2009
- Efficacy and safety of two treatment combinations of hypertension in very elderly patientsArchives of Gerontology and Geriatrics, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1–2 hypertensionJournal of Human Hypertension, 2009
- Supramaximal Dose of Candesartan in Proteinuric Renal DiseaseJournal of the American Society of Nephrology, 2009
- Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure LoweringHypertension, 2008
- A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertensionCurrent Medical Research and Opinion, 2008
- Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertensionClinical Therapeutics, 2007
- 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)European Heart Journal, 2006